Treatment with desidustat resulted in improvement in haemoglobin levels with acceptable tolerability over short-term follow-up similar to erythropoietin. The convenience of oral administration supports its potential role as a patient-centred option for anaemia management following kidney transplantation.
Barak et al. (Wed,) studied this question.